Page last updated: 2024-11-05

o,s,s-trimethyl phosphorodithioate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID31435
SCHEMBL ID259963
MeSH IDM0102932

Synonyms (16)

Synonym
o,s,s-trimethyl phosphorodithioate
phosphorodithioic acid, o,s,s-trimethyl ester
o,s,s-trimethylphosphorodithiolate
brn 1816766
ccris 5583
bis(methylsulfanyl)phosphoryloxymethane
22608-53-3
o,s,s-trimethylphosphorodithioate
AKOS006277647
unii-i8xmp02c4g
i8xmp02c4g ,
(methoxy(methylsulfanyl)phosphoryl)sulfanylmethane
SCHEMBL259963
NIJIQSOYZWDHAQ-UHFFFAOYSA-N
o,s,s-trimethyl dithiophosphate #
DTXSID40177129

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Oral 28-day LD50 of OSS-Me for rats was 67 mg/kg."( Lung injury and delayed toxicity produced by O,S,S-trimethyl phosphorodithioate, an impurity of malathion.
Fukuto, TR; Imamura, T; Konno, N, 1984
)
0.53

Dosage Studied

ExcerptRelevanceReference
" The Clara cells from dosed animals were largely devoid of granules until the 3rd day after administration."( Ultrastructural changes in rat Clara cells induced by a single dose of O,S,S-trimethyl phosphorodithioate.
Dinsdale, D; Ingham, JE; Verschoyle, RD, 1984
)
0.5
" The method has been applied to a pharmacokinetic study in the rat after an oral or intravenous dosage with 25 mg/kg of O,S,S-trimethylphosphorodithioate."( The determination of O,S,S-trimethylphosphorodithioate in the plasma and various tissues of rats using high-resolution gas chromatography with nitrogen-phosphorus detection.
Bailey, E; Peal, JA; Verschoyle, RD, 1981
)
0.26
"This study was designed to test the hypothesis that the reduction in cytochrome P450 (CYP) 2B1 content and activity of rat lung microsomes, following dosing with pneumotoxic trimethylphosphorothioates, results from damage to specific cell types."( Cell-specific loss of cytochrome P450 2B1 in rat lung following treatment with pneumotoxic and non-pneumotoxic trialkylphosphorothioates.
Dinsdale, D; Verschoyle, RD, 2001
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (84.62)18.7374
1990's3 (11.54)18.2507
2000's1 (3.85)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.63 (24.57)
Research Supply Index3.37 (2.92)
Research Growth Index4.00 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]